Literature DB >> 26188862

Equine recurrent uveitis: Human and equine perspectives.

Fernando Malalana1, Amira Stylianides2, Catherine McGowan3.   

Abstract

Equine recurrent uveitis (ERU) is a spontaneous disease characterised by repeated episodes of intraocular inflammation. The epidemiology of ERU has not been fully elucidated, but the condition appears to be much more common in horses than is recurrent uveitis in humans, especially in certain breeds and geographical regions. Both humans and horses show a similarly altered immune response and a marked autoimmune response as the primary disease pathophysiology. However, an inciting cause is not always clear. Potential inciting factors in horses include microbial agents such as Leptospira spp. Microbial factors and genetic predisposition to the disease may provide clues as to why the horse appears so susceptible to this disease. The aim of this review is to discuss the immunology and genetics of ERU, compare the disease in horses with autoimmune anterior uveitis in humans, and discuss potential reasons for the increased prevalence in the horse.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune; Equine recurrent uveitis; Intraocular inflammation; Leptospira spp

Mesh:

Year:  2015        PMID: 26188862     DOI: 10.1016/j.tvjl.2015.06.017

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  9 in total

1.  Unusual presentation of cyathostomiasis in an adult Thoroughbred mare.

Authors:  Emily Zakrajsek
Journal:  Can Vet J       Date:  2017-11       Impact factor: 1.008

Review 2.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

3.  Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide.

Authors:  Caryn E Plummer; Timothy Polk; Jatin Sharma; Sanghyo Sarah Bae; Olivia Barr; Amari Jones; Holly Kitchen; Michelle Wilhelmy; K Devin; W Clay Smith; Bryan D Kolaczkowski; Joseph Larkin
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

4.  Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.

Authors:  Laurel K Saldinger; Seldy G Nelson; Rebecca R Bellone; Mary Lassaline; Maura Mack; Naomi J Walker; Dori L Borjesson
Journal:  Vet Ophthalmol       Date:  2019-08-22       Impact factor: 1.644

5.  Ex Vivo and In Vitro Analysis Identify a Detrimental Impact of Neutrophil Extracellular Traps on Eye Structures in Equine Recurrent Uveitis.

Authors:  Leonie Fingerhut; Leyla Yücel; Katrin Strutzberg-Minder; Maren von Köckritz-Blickwede; Bernhard Ohnesorge; Nicole de Buhr
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

6.  Pre-Activated Granulocytes from an Autoimmune Uveitis Model Show Divergent Pathway Activation Profiles upon IL8 Stimulation In Vitro.

Authors:  Anne L C Hoffmann; Stefanie M Hauck; Cornelia A Deeg; Roxane L Degroote
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

7.  Penetration of topically administered dexamethasone disodium phosphate and prednisolone acetate into the normal equine ocular fluids.

Authors:  Hanneke Hermans; Els M H van den Berg; Inge J M Slenter; Dax J C Vendrig; Lilian J L de Nijs-Tjon; Johannes C M Vernooij; Harold Brommer; Michael H Boevé; Ronette Gehring
Journal:  Equine Vet J       Date:  2021-11-21       Impact factor: 2.692

Review 8.  The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses.

Authors:  Alina Cequier; Carmen Sanz; Clementina Rodellar; Laura Barrachina
Journal:  Animals (Basel)       Date:  2021-03-25       Impact factor: 2.752

9.  The Fecal Bacterial Microbiota in Horses with Equine Recurrent Uveitis.

Authors:  Michelle Martin de Bustamante; Diego Gomez; Jennifer MacNicol; Ralph Hamor; Caryn Plummer
Journal:  Animals (Basel)       Date:  2021-03-09       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.